Literature DB >> 10349062

Raloxifene: designer estrogen for preventing postmenopausal osteoporosis.

L Park1, M F Evans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10349062      PMCID: PMC2328579     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  5 in total

1.  Hormone replacement therapy. Does it actually help with heart disease?

Authors:  M F Evans; F Gerstein
Journal:  Can Fam Physician       Date:  1999-04       Impact factor: 3.275

2.  The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year, double-blind, placebo-controlled study.

Authors:  R J Herd; R Balena; G M Blake; P J Ryan; I Fogelman
Journal:  Am J Med       Date:  1997-08       Impact factor: 4.965

3.  Estrogen replacement therapy. A survey of older women's attitudes.

Authors:  L M Salamone; A R Pressman; D G Seeley; J A Cauley
Journal:  Arch Intern Med       Date:  1996-06-24

4.  Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.

Authors:  P D Delmas; N H Bjarnason; B H Mitlak; A C Ravoux; A S Shah; W J Huster; M Draper; C Christiansen
Journal:  N Engl J Med       Date:  1997-12-04       Impact factor: 91.245

5.  Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

Authors:  D Hosking; C E Chilvers; C Christiansen; P Ravn; R Wasnich; P Ross; M McClung; A Balske; D Thompson; M Daley; A J Yates
Journal:  N Engl J Med       Date:  1998-02-19       Impact factor: 91.245

  5 in total
  2 in total

1.  Does raloxifene reduce risk of vertebral fractures? Is this another, brighter way to treat osteoporosis?

Authors:  S Hathirat; M F Evans
Journal:  Can Fam Physician       Date:  2001-10       Impact factor: 3.275

2.  Comparison of raloxifene and atorvastatin effects on serum lipids composition of healthy post-menopausal women.

Authors:  Christina Piperi; Christos Kalofoutis; Irene Lagogianni; George Troupis; Anastasios Kalofoutis
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.